NASDAQ:ARDS
Aridis Pharmaceuticals, Inc.
- Stock
Market Cap
2.94M
Beta: 0.99
Volume Today
174.90K
Avg: 997.59K
PE Ratio
−4.42
PFCF: −0.20
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -2.06M - | -2.26M 10.05% | -390.50K 82.73% | -302.50K 22.54% | -118.50K 60.83% | |||
average payables | 805.50K - | 1.63M 102.61% | 2.04M 25.18% | 1.82M 10.89% | 3.56M 95.72% | 3.77M 5.92% | ||
average receivables | 33.50K - | 830K 2,377.61% | 1.04M 24.88% | 390.50K 62.33% | 302.50K 22.54% | 738.50K 144.13% | ||
book value per share | 1.75 - | 1.45 16.98% | 8.36 476.98% | 0.43 94.86% | -0.95 320.25% | -1.15 21.24% | -1.29 12.42% | |
capex per share | -0.00 - | -0.09 4,553.33% | -0.22 143.21% | -0.02 90.44% | -0.04 94.58% | -0.04 7.72% | -0.00 89.87% | |
capex to depreciation | -0.65 - | -11.26 1,626.24% | -2.39 78.75% | -0.51 78.48% | -1.09 111.55% | -1.22 11.88% | -0.17 86.18% | |
capex to operating cash flow | 0.00 - | 0.04 1,514.37% | 0.03 29.84% | 0.02 23.54% | 0.02 15.96% | 0.02 28.93% | 0.00 87.82% | |
capex to revenue | -0.01 - | -0.81 12,177.22% | -0.25 69.75% | -0.17 30.67% | -0.37 115.56% | |||
cash per share | 2.83 - | 3.18 12.58% | 7.70 142.17% | 2.47 67.92% | 0.90 63.66% | 1.63 81.10% | 0.26 84.03% | |
days of inventory on hand | ||||||||
days payables outstanding | 128.42 - | |||||||
days sales outstanding | 10.78 - | 219.77 - | 147.50 32.88% | 134.32 8.94% | ||||
debt to assets | 0.08 - | 0.05 - | 0.22 371.68% | 0.42 86.98% | ||||
debt to equity | 0.09 - | -0.08 - | -0.42 414.39% | -0.25 40.29% | ||||
dividend yield | 0.04 - | 0.14 - | ||||||
earnings yield | -0.08 - | -0.24 192.76% | -0.63 163.53% | -0.77 21.57% | -0.39 48.86% | -1.48 274.85% | -1.39 6.00% | |
enterprise value | 80.28M - | 77.48M 3.49% | 10.66M 86.24% | 16.74M 57.07% | 48.14M 187.52% | 14.63M 69.60% | 23.41M 60.01% | |
enterprise value over ebitda | -10.44 - | -5.33 48.91% | -0.41 92.24% | -0.58 39.04% | -2.15 273.33% | -0.33 84.68% | -0.79 140.95% | |
ev to operating cash flow | -13.18 - | -4.41 66.52% | -0.44 90.05% | -2.05 367.24% | -2.35 14.57% | -0.64 72.86% | -0.80 26.00% | |
ev to sales | 35.38 - | 90.09 154.62% | 3.87 95.71% | 16.38 323.72% | 48.14 193.84% | |||
free cash flow per share | -0.77 - | -2.31 198.97% | -7.93 242.69% | -0.99 87.57% | -2.27 130.74% | -1.91 16.02% | -1.56 18.52% | |
free cash flow yield | -0.06 - | -0.18 198.97% | -0.71 301.71% | -0.22 69.03% | -0.37 69.16% | -0.82 118.78% | -1.32 60.89% | |
graham net net | 1.72 - | 1.27 25.96% | 5.76 352.17% | -0.39 106.83% | -1.69 328.58% | -1.70 0.56% | -1.76 3.93% | |
graham number | 6.48 - | 10.09 55.90% | 36.36 260.15% | 5.76 84.16% | 7.14 23.95% | 9.43 32.08% | 6.90 26.84% | |
income quality | 0.72 - | 0.71 1.54% | 1.10 54.19% | 0.27 74.96% | 0.92 233.53% | 0.54 40.71% | 0.96 76.42% | |
intangibles to total assets | 0.00 - | 0.00 23.75% | 0.00 25.98% | 0.00 4.82% | 0.00 56.10% | 0.00 54.03% | 0.00 40.91% | |
interest coverage | -21.54 - | -57.42 - | 178.41 - | -79.35 144.47% | ||||
interest debt per share | 0.05 - | 0.92 - | 0.08 - | 0.47 498.10% | 0.35 25.69% | |||
inventory turnover | ||||||||
invested capital | 0.09 - | -0.08 - | -0.42 414.39% | -0.25 40.29% | ||||
market cap | 102.57M - | 102.57M 0% | 34.90M 65.98% | 37.64M 7.86% | 55.65M 47.86% | 28.64M 48.54% | 22.16M 22.63% | |
net current asset value | 13.65M - | 10.30M 24.54% | 18.94M 83.92% | 3.64M 80.80% | -8.68M 338.75% | -14.11M 62.54% | -27.30M 93.49% | |
net debt to ebitda | 2.90 - | 1.73 40.40% | 0.94 45.52% | 0.72 23.68% | 0.34 53.29% | 0.32 6.05% | -0.04 113.48% | |
net income per share | -1.07 - | -3.12 192.76% | -7.02 124.81% | -3.43 51.22% | -2.39 30.24% | -3.44 43.89% | -1.64 52.39% | |
operating cash flow per share | -0.77 - | -2.23 188.24% | -7.71 246.64% | -0.96 87.49% | -2.23 131.52% | -1.87 16.44% | -1.55 16.87% | |
payables turnover | 2.84 - | |||||||
receivables turnover | 33.87 - | 1.66 - | 2.47 49.00% | 2.72 9.81% | ||||
research and ddevelopement to revenue | 2.76 - | 20.28 634.83% | 8.34 58.86% | 23.56 182.47% | 16.96 28.04% | |||
return on tangible assets | -0.37 - | -0.93 149.06% | -0.70 24.94% | -1.04 48.21% | -1.45 39.99% | -1.58 8.72% | -2.09 32.66% | |
revenue per share | 0.29 - | 0.11 62.10% | 0.88 703.87% | 0.12 86.21% | 0.11 9.73% | |||
roe | -0.61 - | -2.16 252.63% | -0.84 61.04% | -7.97 848.99% | 2.52 131.67% | 3.00 18.68% | 1.27 57.65% | |
roic | -0.61 - | -2.07 239.99% | -0.93 55.10% | -7.81 740.56% | 2.76 135.33% | 5.26 90.64% | 1.87 64.53% | |
sales general and administrative to revenue | 0.87 - | 3.67 324.29% | 1.41 61.76% | 5.90 319.62% | 6.45 9.31% | |||
shareholders equity per share | 1.75 - | 1.45 16.98% | 8.36 476.98% | 0.43 94.86% | -0.95 320.25% | -1.15 21.24% | -1.29 12.42% | |
stock based compensation to revenue | 0.38 - | 1.87 394.46% | 0.60 67.84% | 1.97 227.04% | 2.13 8.20% | |||
tangible asset value | 13.73M - | 11.39M 17.00% | 26.28M 130.63% | 3.60M 86.28% | -8.71M 341.62% | -14.13M 62.29% | -24.25M 71.59% | |
tangible book value per share | 1.74 - | 1.44 17.00% | 8.35 478.32% | 0.43 94.90% | -0.95 322.90% | -1.15 21.06% | -1.29 12.32% | |
working capital | 20.01M - | 22.17M 10.76% | 18.94M 14.55% | 8.64M 54.40% | -7.32M 184.80% | -6.55M 10.53% | -25.27M 285.71% |
All numbers in USD (except ratios and percentages)